WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 325

Legislative bill overview

HB 325 modifies Hawaii's medical cannabis program, though the specific amendments aren't detailed in the legislative record provided. The bill passed its second reading with amendments (HD 1) and was referred to the Consumer Protection and Commerce committee before being carried over to the 2026 session for further consideration.

Why is this important

Medical cannabis policy affects patient access to treatment options, regulatory frameworks, and potential tax revenue in Hawaii. The bill's progression through committees suggests substantive debate about how to structure or expand the state's existing medical cannabis system.

Potential points of contention

  • Patient access vs. regulatory safety: Balancing expanded patient eligibility or dispensary availability against concerns about oversight and misuse
  • Implementation costs: Committee amendments likely addressed funding mechanisms, licensing fees, or regulatory infrastructure
  • Industry structure: Disagreements may exist over whether to favor existing license holders, allow new entrants, or modify vertical integration rules

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.